Scholars Central

Research articlePublished 2015

Long-Term Efficacy of Nevirapine Plus Co-Formulated Abacavir/Lamividune as Simplification Therapy in HIV-Infected Patients with Undetectable Viral Load

Authors: Alfonso Cabello, José Casas, Juan Alfredo López, Rosa García Delgado, Manuel L. Fernández Guerrero, Miguel Górgolas

Journal of AIDS & Clinical Research

Volume 6 · Issue 5 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: The long-term efficacy of NVP+ABC+3TC as a simplification strategy for the treatment of HIV-1 infected patients with undetectable viral load has not been properly assessed in randomized trials. This low-cost treatment with limited renal and bone side effects must be of particular interest in this era of cost-containment urgency and also in limited resource settings. Methods: Observational study of 232 HIV1-infected patients with undetectable viral load who initiated nevirapine (NVP) + abacavir (ABC) + lamivudine (3TC). Reasons for the switching were treatment simplification (56%), renal problems (6%), osteopenia/osteoporosis (7%), hyperlipidemia (11%) and others (20%). HIV-1 viral load, CD4 cell count and fasting biochemistry profiles were determined on a routine clinical practice. The aim of the study was to evaluate long-term efficacy of this combination and its effect on renal function and lipid metabolism. Results: 232 patients had a mean follow-up of 4 years (712 patients-year). The mean increment of CD4 after 4 years was 83 cells/μL (13% from baseline). Viral load remained undetectable in all but 14 patients (6%). Triglycerides levels decreased by 10% overtime (p < 0,05). 25 patients (10,7%) stopped therapy due to NVP associated side effects; no ABC associated side-effects were observed. No changes were found in renal function or bone mineral density. Conclusions: The combination of NVP+ABC+3TC is a safe option for maintaining longterm viral suppression and immunological control, preserving renal function and improving hypertriglyceridemia.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of AIDS & Clinical Research
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Alfonso Cabello”
  • BylineArticles whose byline prints “José Casas”
  • BylineArticles whose byline prints “Juan Alfredo López”
  • BylineArticles whose byline prints “Rosa García Delgado”
  • BylineArticles whose byline prints “Manuel L. Fernández Guerrero”
  • BylineArticles whose byline prints “Miguel Górgolas”